Skip to content

Paper Spotlight: Sharing R&D Risk in Healthcare via FDA Hedges

                          Recent estimates suggest that the cost of developing a single new drug in the biopharmaceutical sector is $2.6 billion, confirming the very large amounts of money that medical companies invest to develop a new treatment. Biomedical companies also face the risk of very low rates of success, not only due to the inherent scientific risk of developing… Read More »Paper Spotlight: Sharing R&D Risk in Healthcare via FDA Hedges

Forthcoming Paper

“Board Reforms, Stock Liquidity, and Stock Market Development” by Buhui Qiu and Thomas To

Invitation to Bid: SFS Cavalcade

The Society for Financial Studies invites bids to host future Cavalcades. We are currently accepting bids for 2024-2026. Please see the Invitation to Bid. Deadline to submit bids: September 15, 2022.

Forthcoming Papers

“COVID-19 and Corporate Finance” by Marco Pagano and Josef Zechner “How Does Corporate Governance Impact Equity Volatility? Worldwide Evidence and Theory” by Alexandre Jeanneret and Louis Gagnon

Advisory Editor

We are pleased to welcome Peter C. Mueller to the advisory editor team. Peter is a fourth year PhD candidate in finance at the University of Oklahoma. We thank Tengfei Zhang for his service in the advisory editor role, and wish him the best of luck in his new role as an Assistant Professor of Finance at Rutgers School of Business–Camden.

Prior Review Process

RCFS has a submission option for papers that were previously reviewed by other journals. The goal of such review process is to help the editors arrive at a quick and informed decision on a paper based on feedback received by the authors from previous submissions. A paper is eligible for this optional review process if it was previously submitted to a few select journals; please see Prior Review Policy for details. If… Read More »Prior Review Process